Neurology Central talks to David Burn, Clinical Director at Parkinson’s UK, to discuss the recently launched Parkinson’s Excellence Network, and the future of Parkinson’s disease treatment and care in the UK.
Browsing: Cognitive/neurodegenerative disorders
Available to view on demand: the UC Davis research team present an update on preclinical development of their cell-gene therapy…
This commentary discusses the role of epigenomics in the neurodegeneration of ataxia-telangiectasia
This review examines the research efforts that have focused on the role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer’s disease
Political, economic and organizational factors shape requirements for long-term aged care (LTC) serving people with chronic conditions, including dementia. Organization…
This review is a concise summary of nonmotor symptoms in both genetic and idiopathic Parkinson’s disease patients, highlighting the importance of nonmotor symptoms in research and clinical practice of Parkinson’s disease together with some of the potential differences in pathophysiology and clinical features.